AngioDynamics, Inc. (NASDAQ:ANGO) Files An 8-K Results of Operations and Financial ConditionItem 2.02 –Results of Operations and Financial Condition
99.1
Press Release, dated July 18, 2017.*
99.2
Updated Fiscal 2017 Fourth Quarter and Full-Year Financial Results.
* Previously furnished as an exhibit to the Original Report.
ANGIODYNAMICS INC ExhibitEX-99.2 2 an20170804-ex99_2.htm UPDATED FISCAL 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS Exhibit 99.2 ANGIODYNAMICS,…To view the full exhibit click here
About AngioDynamics, Inc. (NASDAQ:ANGO)
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company’s BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.
